Biospring Partners ABZ Fund, L.P. — Form D/A
Biospring Partners ABZ Fund, L.P. of New York, NY, a pooled investment fund, filed a Form D amendment with the SEC on 2022-07-20. The offering totals $12.1M, of which $12.1M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-07-20
- Form: D/A
- Accession: 0001817040-22-000001
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1, 3C.7
- Total offering: $12.1M
- Amount sold: $12.1M
- Investors: 7
- Date of first sale: 2020-07-21
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-371038
Issuer
- Name: Biospring Partners ABZ Fund, L.P.
- CIK: 0001817040
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 50 West 57th Street, 7th Floor, New York, NY, 10019
- Phone: 646-777-8417
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Michelle Dipp | Director | BOSTON, MA |
| Jennifer Lum | Director | New York, NY |
| n/a Biospring Management, LLC | Promoter | New York, NY |
| n/a Biospring Partners Fund GP, LLC | Promoter | New York, NY |
| Jennifer Lum | Executive Officer | New York, NY |
| Michelle Dipp | Executive Officer | BOSTON, MA |
Other filings by this issuer (1)
More